Hyperparathyroidism Clinical Trials

8 recruiting

Hyperparathyroidism Trials at a Glance

31 actively recruiting trials for hyperparathyroidism are listed on ClinicalTrialsFinder across 6 cities in 28 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Philadelphia, Taipei, and Bethesda. Lead sponsors running hyperparathyroidism studies include Shaanxi Micot Pharmaceutical Technology Co., Ltd., Amgen, and Aarhus University Hospital.

Browse hyperparathyroidism trials by phase

Treatments under study

About Hyperparathyroidism Clinical Trials

Looking for clinical trials for Hyperparathyroidism? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperparathyroidism trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperparathyroidism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Phase 2Phase 3

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

Primary HyperparathyroidismParathyroid CancerMultiple Endocrine Neoplasias+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)193 enrolled1 locationNCT07444723
Recruiting

Natural History Study of Parathyroid Disorders

Primary HyperparathyroidismParathyroid CancerPseudohypoparathyroidism+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3,000 enrolled1 locationNCT04969926
Recruiting

Parathyroid Tumor Clonal Status

Primary HyperparathyroidismParathyroid Tumor
Washington University School of Medicine839 enrolled1 locationNCT05997810
Recruiting
Phase 3

A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Secondary Hyperparathyroidism
Amgen24 enrolled23 locationsNCT03969329
Recruiting
Not Applicable

Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism

Hyperparathyroidism, Primary
University of Pennsylvania76 enrolled1 locationNCT06562881
Recruiting
Phase 3

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Chronic Kidney DiseaseSecondary Hyperparathyroidism
Amgen56 enrolled43 locationsNCT03633708
Recruiting
Not Applicable

Parathyroidectomy After Kidney Transplantation

HyperparathyroidismKidney Transplantation Recipients
Aarhus University Hospital85 enrolled1 locationNCT07415421
Recruiting

Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases

GliomaPrimary HyperparathyroidismAmino-Acid Transport Disorder
Tianjin Medical University500 enrolled2 locationsNCT07379463
Recruiting
Phase 1

A Mass Balance Study of [14C] MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism

Hemodialysis Subjects With Secondary Hyperparathyroidism
Shaanxi Micot Pharmaceutical Technology Co., Ltd.6 enrolled1 locationNCT07284043
Recruiting

Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

Primary HyperparathyroidismParathyroid Gland CarcinomaParathyroid Gland Atypical Adenoma+1 more
M.D. Anderson Cancer Center310 enrolled1 locationNCT03039439
Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Heart FailureSarcopeniaOsteoporosis+11 more
Bettina Mittendorfer100 enrolled1 locationNCT07083557
Recruiting
Phase 3

Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism, Chronic Kidney Disease
Shaanxi Micot Pharmaceutical Technology Co., Ltd.424 enrolled1 locationNCT07122401
Recruiting

Parathyroidectomy and Mobility Study

MobilityHyperparathyroidismParathyroid
University of Florida80 enrolled1 locationNCT07103876
Recruiting

Cohort Primary Hyperparathyroidism

Primary Hyperparathyroidism
Nantes University Hospital403 enrolled1 locationNCT05469087
Recruiting
Not Applicable

18F-choline Positron-emission-tomography - Computed-tomography Compared to Conventional Imaging for Localizing Diseased Parathyroid Glands in Primary Hyperparathyroidism

Primary Hyperparathyroidism
Region Skane88 enrolled1 locationNCT07138820
Recruiting

Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)

Thyroid NeoplasmsHyperparathyroidismParathyroid Gland
Bo Wang,MD180 enrolled1 locationNCT07010380
Recruiting
Phase 2

Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis

Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd.310 enrolled1 locationNCT06976177
Recruiting
Phase 4

Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism

Primary Hyperparathyroidism
University of Aarhus140 enrolled1 locationNCT06859580
Recruiting
Not Applicable

Autofluorescence in Surgery for Primary Hyperparathyroidism

Hyperparathyroidism, Primary
Aarhus University Hospital100 enrolled1 locationNCT06230380
Recruiting

Establishment of a Registry of Patients With Parathyroid Disease

HypoparathyroidismHyperparathyroidism
IRCCS Azienda Ospedaliero-Universitaria di Bologna1,200 enrolled1 locationNCT06797934